SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-126256
Filing Date
2020-04-29
Accepted
2020-04-29 16:21:04
Documents
8
Period of Report
2020-06-29
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d854810ddef14a.htm DEF 14A 346492
2 GRAPHIC g854810g11y77.jpg GRAPHIC 26592
3 GRAPHIC g854810g21j11.jpg GRAPHIC 24658
4 GRAPHIC g854810g24p24.jpg GRAPHIC 23255
5 GRAPHIC g854810g45a86.jpg GRAPHIC 37394
6 GRAPHIC g854810g48k66.jpg GRAPHIC 28639
7 GRAPHIC g854810g56z83.jpg GRAPHIC 16586
8 GRAPHIC g854810g57f70.jpg GRAPHIC 22487
  Complete submission text file 0001193125-20-126256.txt   595626
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: DEF 14A | Act: 34 | File No.: 001-37695 | Film No.: 20830644
SIC: 2834 Pharmaceutical Preparations